Genome-wide association studies in pharmacogenomics.
Daly
Ann K
AK
Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne NE2 4HH, UK. a.k.daly@ncl.ac.uk
D000925:Anticoagulants / Q000008:administration & dosage; D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics; D056486:Chemical and Drug Induced Liver Injury / Q000235:genetics; D065729:Cytochrome P-450 CYP2C9; D064420:Drug-Related Side Effects and Adverse Reactions / Q000235:genetics; D005436:Floxacillin / Q000009:adverse effects; D055106:Genome-Wide Association Study / Q000379:methods* / Q000639:trends; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage; D006899:Mixed Function Oxygenases / Q000235:genetics; D009135:Muscular Diseases / Q000139:chemically induced / Q000235:genetics; D010597:Pharmacogenetics / Q000379:methods* / Q000639:trends; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage; D019821:Simvastatin / Q000009:adverse effects; D064417:Vitamin K Epoxide Reductases
D000925:Anticoagulants; D016898:Interferon-alpha; D010975:Platelet Aggregation Inhibitors; D005436:Floxacillin; D019821:Simvastatin; D006899:Mixed Function Oxygenases; C450260:CYP2C9 protein, human; D065729:Cytochrome P-450 CYP2C9; D001189:Aryl Hydrocarbon Hydroxylases; D064417:Vitamin K Epoxide Reductases